EP Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,661
Closed -$405K 1454
2025
Q1
$405K Sell
3,661
-150
-4% -$16.6K ﹤0.01% 784
2024
Q4
$520K Sell
3,811
-380
-9% -$51.9K ﹤0.01% 684
2024
Q3
$483K Buy
+4,191
New +$483K ﹤0.01% 706